MedTrace Logo

Impact of External Nasal Dilator on the Rhinogram

NCT01411969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2011-08-08

No results posted yet for this study

Summary

The aim of this study is to present new data for a better understanding of the anatomic correlation of these two notches.

This study included 32 nasal cavities (16 individuals) with external nasal dilator strip (Breath Right®) and after decongestion (0.05% oxymetazoline chloride applied as an aerosol spray);

Conditions

  • Nasal Obstruction

Interventions

DRUG

External Nasal Dilator Strip; 0.05% oxymetazoline chloride

External Nasal Dilator Strip placed above the upper lateral cartilage; 20 minutes after decongestion with 0.05% oxymetazoline chloride applied as an aerosol spray (two times); after decongestion with ENDS.

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Joao F Mello-Jr, Ph.D · University of Sao Paulo General Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-07-31
Completion
2010-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01411969 on ClinicalTrials.gov